Cleared Traditional

K942964 - LACTATE DEHYDROGENASE QVET

K942964 is an FDA 510(k) clearance for LACTATE DEHYDROGENASE QVET, manufactured by Prisma Systems. The device is a Class 2 Chemistry device with product code CFJ cleared through the Traditional 510(k) pathway after a 189-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1994
Decision
189d
Days
Class 2
Risk

K942964 is an FDA 510(k) clearance for the LACTATE DEHYDROGENASE QVET. Classified as Nad Reduction/nadh Oxidation, Lactate Dehydrogenase (product code CFJ), Class II - Special Controls.

Submitted by Prisma Systems (Rome, US). The FDA issued a Cleared decision on December 29, 1994 after a review of 189 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1440 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Prisma Systems devices

FDA 510(k) Submission Details - K942964

510(k) Number K942964 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 1994
Decision Date December 29, 1994
Days to Decision 189 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
101d slower than avg
Panel avg: 88d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFJ Device Classification - Class 2, Special Controls

Product Code CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase

All 87
Devices cleared under the same product code (CFJ) and FDA review panel - the closest regulatory comparables to K942964.
LACTATE DEHYDROGENASE REAGENT SET
K961431 · Pointe Scientific, Inc., · Jun 1996
LACTATE DEHYDROGENASE REAGENT SYSTEM
K952747 · Medical Diagnostic Technologies, Inc. · Aug 1995
HICHEM LDH/L REAGENT KIT
K946022 · Hichem Diagnostics · Feb 1995
LACTATE DEHYDROGENASE (LD)
K935175 · Em Diagnostic Systems, Inc. · Dec 1993
LACTATE DEHYDROGENASE (LD) TEST ITEM #65418
K924703 · Em Diagnostic Systems, Inc. · Feb 1993
OLYMPUS LACTATE DEHYDROGENASE REAGENT
K924965 · Olympus Corp. · Nov 1992